Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Equity Ratio (2016 - 2020)

Trinity Biotech (TRIB) has disclosed Equity Ratio for 5 consecutive years, with 0.02 as the latest value for Q4 2020.

  • Quarterly Equity Ratio fell 147.33% to 0.02 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 0.02 through Dec 2020, down 147.33% year-over-year, with the annual reading at 0.02 for FY2020, 147.33% down from the prior year.
  • Equity Ratio hit 0.02 in Q4 2020 for Trinity Biotech, down from 0.04 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.44 in Q4 2016 to a low of 0.02 in Q4 2020.
  • Historically, Equity Ratio has averaged 0.22 across 5 years, with a median of 0.29 in 2018.
  • Biggest five-year swings in Equity Ratio: decreased 14.02% in 2018 and later tumbled 147.33% in 2020.
  • Year by year, Equity Ratio stood at 0.44 in 2016, then fell by 22.44% to 0.34 in 2017, then decreased by 14.02% to 0.29 in 2018, then plummeted by 87.62% to 0.04 in 2019, then crashed by 147.33% to 0.02 in 2020.
  • Business Quant data shows Equity Ratio for TRIB at 0.02 in Q4 2020, 0.04 in Q4 2019, and 0.29 in Q4 2018.